Ally Bruno
Mr. Ippolito
AP Biology D Even
December 20, 2018
Grady, Denise. “How Can We Unleash the Immune System?” The New York Times, The New York Times, 20 Nov. 2018, www.nytimes.com/2018/11/19/health/cancer-immunotherapy-drugs.html.
The article “How we can Unleash the Immune System” by Denise Grady delves into the idea the human immune system can be manipulated to attack cancer. Grady opens her article by acknowledging the fact that immunotherapy treatments have only been in less than half of all its patience but she remains hopeful for the future. Grady goes on to discuss the current experiments the are being performed to “fine-tune the treatments”. Grady opened her argument by differentiating between the two types of immunotherapy cancer treatments. Both Checkpoint inhibitors and CAR-T cells work to activate a specific type of white blood cell that can removes cells that have become malignant and cancerous. She then goes on to cite a doctor from Memorial Sloan Kettering Cancer Center who is optimistic about immunotherapy research that might one out of his facility. She even includes an example of year old cancer patient who has been in remission and thriving from his treatments.
After reading Grady’s article, the reader can tell that she is clearly invested in her topic. She did a great job of evoking emotion from her readers by including and patients successes and statistics about the lives that could be saved if this treatment proves to be useful. I do not however, believe that Grady did an adequate job of providing enough information about the new research programs that are testing immunotherapy. While, she described the types of immunotherapy in a very clearly and sufficiently, she never explains what types of research is being performed to enhance the understanding of immunotherapy and possible treatment options.
Since cancer is one of the most deadly diseases in the US, any type of innovation in the treatment options is vital to the scientific worlds. The topic is so important because it discusses it gives an optimistic and positive outlook on the possibility of improving the way patients with cancer are able to leave their lives. Chemo treatments are effective today but are detrimental to the over health and lifestyle of cancer patients and immunotherapy seeks a new way of increasing patients survival rates helping them maintain stable and fulfilling lives while they are being treated.